Alghamdi, A.; Bijlsma, M.J.; de Vos, S.; Schuiling-Veninga, C.C.M.; Bos, J.H.J.; Hak, E.
Association between Incidence of Prescriptions for Alzheimer’s Disease and Beta-Adrenoceptor Antagonists: A Prescription Sequence Symmetry Analysis. Pharmaceuticals 2023, 16, 1694.
https://doi.org/10.3390/ph16121694
AMA Style
Alghamdi A, Bijlsma MJ, de Vos S, Schuiling-Veninga CCM, Bos JHJ, Hak E.
Association between Incidence of Prescriptions for Alzheimer’s Disease and Beta-Adrenoceptor Antagonists: A Prescription Sequence Symmetry Analysis. Pharmaceuticals. 2023; 16(12):1694.
https://doi.org/10.3390/ph16121694
Chicago/Turabian Style
Alghamdi, Ali, Maarten J. Bijlsma, Stijn de Vos, Catharina C.M. Schuiling-Veninga, Jens H. J. Bos, and Eelko Hak.
2023. "Association between Incidence of Prescriptions for Alzheimer’s Disease and Beta-Adrenoceptor Antagonists: A Prescription Sequence Symmetry Analysis" Pharmaceuticals 16, no. 12: 1694.
https://doi.org/10.3390/ph16121694
APA Style
Alghamdi, A., Bijlsma, M. J., de Vos, S., Schuiling-Veninga, C. C. M., Bos, J. H. J., & Hak, E.
(2023). Association between Incidence of Prescriptions for Alzheimer’s Disease and Beta-Adrenoceptor Antagonists: A Prescription Sequence Symmetry Analysis. Pharmaceuticals, 16(12), 1694.
https://doi.org/10.3390/ph16121694
